How should I present a goal‑of‑care discussion for a patient with stage 3–5 chronic kidney disease and comorbid hypertension, diabetes, cardiovascular disease, anemia, and mineral‑bone disorder, incorporating disease trajectory, treatment options, and the patient’s values and preferences?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Goal-of-Care Discussion Framework for Advanced CKD with Multiple Comorbidities

Begin goal-of-care discussions early in the disease trajectory—ideally at stage 3 CKD—using a structured shared decision-making process that prioritizes the patient's values, preferences, and quality of life over disease-specific metrics, and revisit these discussions regularly as the patient's health status evolves. 1

Timing and Initiation of Discussions

  • Start advance care planning conversations when patients reach stage 3 CKD, not waiting until dialysis is imminent, as this allows adequate time for patients to process information and make informed decisions aligned with their values 1
  • Revisit goals of care at each clinical transition: when eGFR declines by >5 mL/min/1.73 m² per year, with new hospitalizations, when complications emerge (anemia, mineral-bone disorder), and at least annually for stable patients 1
  • Recognize that patients focus on living well in the present while clinicians tend to focus on future dialysis preparation—explicitly acknowledge this tension and validate both perspectives 2

Structured Communication Framework

Use the "Ask-Tell-Ask" method to structure conversations: first elicit what the patient already knows and wants to know, then share medical information in plain language, then check understanding and invite questions 1

Step 1: Assess Patient's Current Understanding and Priorities

  • Ask: "What do you understand about your kidney disease and where it's heading?" 1
  • Explore: "What matters most to you in your daily life right now?" and "What are you hoping treatment can help you achieve?" 1
  • Identify competing priorities: patients with multiple comorbidities (hypertension, diabetes, cardiovascular disease) may not prioritize CKD management above other concerns—acknowledge this explicitly 2
  • Consider cultural context: in many cultures, family and community have central roles in decision-making, so identify who should be included in discussions 1

Step 2: Present Disease Trajectory in Plain Language

  • Explain that CKD stages 3-5 represent progressive kidney damage that cannot be reversed, but progression can be slowed with treatment 1
  • Provide realistic prognosis using validated prediction tools: calculate 2-year kidney failure risk and present this numerically (e.g., "Based on your current kidney function, you have a X% chance of needing dialysis within 2 years") 1
  • Describe the trajectory of complications: anemia causing fatigue, mineral-bone disorder causing bone pain and fractures, cardiovascular disease progression, and eventual need for kidney replacement therapy if disease progresses 1, 3
  • Avoid medical jargon—use terms like "kidney function" rather than "eGFR," and "protein in urine" rather than "albuminuria" 1

Step 3: Present Treatment Options with Benefits and Burdens

Frame treatment options around what matters to the patient, not just clinical outcomes:

Disease-Modifying Therapies

  • ACE inhibitors/ARBs and SGLT2 inhibitors slow kidney function decline and reduce cardiovascular events, but require monitoring for hyperkalemia and may cause initial eGFR dip 1
  • Present absolute risk reductions, not just relative risks: "This medication reduces your risk of kidney failure by X% over Y years" 1

Management of Complications

  • Anemia treatment with ESAs or iron improves energy and quality of life but requires regular monitoring 1, 3
  • Phosphate binders and vitamin D analogs for mineral-bone disorder prevent fractures but involve taking multiple pills with meals 3
  • Blood pressure and glucose control reduce cardiovascular events but may increase medication burden 1

Kidney Replacement Therapy Options

  • Hemodialysis: 3 times weekly, 3-4 hours per session, requires vascular access, provides social interaction at dialysis center but limits flexibility 1
  • Peritoneal dialysis: Daily at home, more flexibility and independence, but requires manual dexterity and dedicated space at home 1
  • Kidney transplantation: Best long-term outcomes and quality of life, but requires surgery, lifelong immunosuppression, and suitable donor 1
  • Comprehensive conservative care (non-dialysis pathway): Focus on symptom management and quality of life without dialysis, appropriate for patients prioritizing comfort over life prolongation 1

Step 4: Explicitly Address the Conservative Care Option

  • Present comprehensive conservative care as a legitimate treatment option, not a "giving up" approach—it focuses on maximizing quality of life through symptom management, supportive care, and avoiding burdensome interventions 1
  • Appropriate for patients with: limited life expectancy from comorbidities, poor functional status, strong preference to avoid dialysis, or those for whom dialysis would provide minimal survival benefit 1
  • Clarify that choosing conservative care does not mean abandoning the patient—it involves active symptom management, psychosocial support, and hospice services when appropriate 1

Addressing Power Dynamics and Ensuring True Shared Decision-Making

Recognize that patients perceive significant power imbalances in the clinician-patient relationship and may hesitate to express preferences that differ from perceived medical recommendations. 2

  • Explicitly state: "There is no single 'right' answer here—the best choice depends on what matters most to you" 1, 2
  • Avoid presenting dialysis as the default or inevitable option; frame all options as equally valid choices based on patient values 2
  • Ask: "What concerns do you have about any of these options?" and "What would make you choose one option over another?" 1
  • Validate patient concerns even when they conflict with clinical guidelines: "I hear that you're more concerned about [patient priority] than [clinical metric]—let's talk about how we can address that" 2

Documenting Goals and Preferences

  • Document specific patient-stated goals (e.g., "wants to maintain independence," "prioritizes time with grandchildren," "wants to avoid hospitalizations") not just treatment choices 1
  • Complete formal advance directives including: preferences for dialysis initiation/withdrawal, preferences for hospitalization and intensive care, and identification of healthcare proxy 1
  • Use tools like the "Five Wishes" document or "Prepare for Your Care" website to facilitate structured advance care planning 1
  • Document health states in which patient would want to withdraw dialysis (e.g., severe dementia, persistent vegetative state, intractable pain) 1

Multidisciplinary Team Involvement

  • Involve nephrology, primary care, cardiology (for cardiovascular disease), endocrinology (for diabetes), pharmacy (for medication management), nutrition, and social work in coordinated care planning 1
  • Assign a care coordinator to help patients navigate appointments, medication changes, and transitions between care settings 1
  • Consider palliative care consultation early (not just at end-of-life) for complex symptom management and additional support with goals-of-care discussions 1

Common Pitfalls to Avoid

  • Delaying discussions until dialysis is imminent: This leaves inadequate time for informed decision-making and often results in emergency dialysis starts that don't align with patient preferences 1, 2
  • Presenting dialysis as the only option: Many patients are unaware that conservative care is a legitimate alternative, leading to unwanted dialysis initiation 1
  • Focusing solely on clinical guidelines rather than patient values: Patients perceive this as a "one-size-fits-all" approach that ignores their individual circumstances 2
  • Assuming family members know patient preferences: Surrogates are often inaccurate in predicting patient wishes without explicit prior discussions 1
  • Failing to address depression and cognitive dysfunction: These barriers significantly impair decision-making capacity and must be identified and treated 1

Ongoing Reassessment

  • Reassess goals of care at every significant clinical change: hospitalization, functional decline, new diagnosis, or change in prognosis 1
  • Recognize that patient preferences may change over time as they experience disease progression and treatment burdens—maintain flexibility to revise plans 1
  • Use validated symptom assessment tools (e.g., Edmonton Symptom Assessment Scale-Renal, Dialysis Symptom Index) to objectively track symptom burden and quality of life 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Challenges to Shared Decision Making About Treatment of Advanced CKD: A Qualitative Study of Patients and Clinicians.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2022

Research

Complications in Patients with Chronic Kidney Disease.

Critical care nursing clinics of North America, 2022

Related Questions

What is the approach to working up and managing adult patients with chronic kidney disease (CKD) stages 3-5, particularly those with a history of hypertension or diabetes?
What is the best treatment plan for a patient with Chronic Kidney Disease (CKD)?
What are the 4 pillars of medication for a patient with Chronic Kidney Disease (CKD)?
What are the symptoms and management strategies for a patient with stage 3a Chronic Kidney Disease (CKD)?
What is the initial workup and management for a patient with chronic kidney disease (CKD)?
What could be causing intermittent facial muscle fasciculations that produce a half‑smile on one side and resolve with a full voluntary smile?
Can Elequis (apixaban) be used as an alternative to clopidogrel (cloprogel) for my patient?
Are transcutaneous electrical nerve stimulation (TENS) and functional electrical stimulation (FES) curative treatments for wrist drop?
Does hemifacial spasm occur at rest?
After a high‑risk sexual exposure (men who have sex with men), I started post‑exposure prophylaxis 21 hours later and completed the 28‑day regimen; I now have negative fourth‑generation antigen/antibody assays at 6, 13, and 18 weeks, a negative proviral DNA test at 6 weeks, and a negative HIV RNA PCR test at 13 weeks—am I definitively not infected with HIV?
What is the appropriate follow‑up and further evaluation for a patient with left pelvi‑ureteric junction (PUJ) stenosis identified on a 6‑month urinary tract ultrasound showing mild‑to‑moderate left hydronephrosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.